Researchers from the Centre for Cell Immunotherapy at the Warsaw University of Life Sciences, led by Prof Magdalena Król, have discovered that could revolutionise the treatment of solid tumours. They have developed an innovative Macrophage-Drug Conjugate (MDC) technology - a breakthrough platform that turns macrophages into precise carriers of anti-cancer drugs.